Covidien LP

Nellcor Puritan Bennett Incorporated

Koninklijke Philips Corporation N.v.

Ric Investments, Inc.

Cividien LP

Nellcor Purtian Bennett LLC

Peter Doyle

Gardner Kimm

Gary Milne

Kirk Hensley

Warren G Sanborn

Dan Graboi

Milenko Masic

Phyllis Rae Angelico

Kenneth Leone

Mehdi Matthew Jafari

Joseph Douglas Vandine

Marc E Palmer

Paul Stanley Addison

James Nicholas Watson

Gabriel Sanchez

Gail Frances Upham

Fernando Jose Isaza

David Hyde

Richard Nakai

Daniel George Graboi

Donna Cleveland

Cynthia Miller

Stanley Y Wong

Samir Saleh Ahmad

Jeffrey K Aviano

Rhomere S Jimenez

Robert William Murdoch

Bernard F Hete

Kenneth E Cole

Adam Jacob Seiver

Marci Emily Palm

Kadri Jabri

Itzhak Verona

Methods and systems are provided for determining fluid administration. The system may determine fluid administration based on the fluid responsiveness and regional oxygen saturation of a subject. The system may receive the fluid responsiveness and regional oxygen saturation from external sources or may determine one or both based on received physiological signals. In some embodiments, the system may determine whether to administer fluid based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the amount of fluid to administer based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the effectiveness of fluid administration. In some embodiments, the system may provide an indication of the determined fluid administration so that a care-giver can implement the appropriate fluid administration. In some embodiments, the system may control the fluid administration based on its determination.

Methods and systems for determining fluid administration

This disclosure describes systems and methods for providing drive pressure ventilation of a patient. The disclosure describes a novel breath type that provides a spontaneous breath type that allows for the calculation of drive pressure that does not require invasive monitoring.

Systems and methods for drive pressure spontaneous ventilation

A gas delivery apparatus configured for use with a mechanical ventilator having an atmospheric inlet for drawing in atmospheric gas includes a connecting device configured to connect to an oxygen supply and an air supply and to deliver mixed air and oxygen gas to the atmospheric inlet of the mechanical ventilator. The connecting device further includes a user control for adjusting a fraction of oxygen in the mixed air and oxygen gas. The connecting device comprises a reservoir configured to hold a volume of the mixed air and oxygen gas.

Systems and methods for providing controlled supplemental oxygen via any ventilator

This disclosure describes systems and methods for controlling pressure and/or flow during exhalation. The disclosure describes novel exhalation modes for ventilating a patient.

Methods and systems for exhalation control and trajectory optimization

This disclosure describes systems and methods for managing a move of a patient being monitored or treated by a medical system, such as a medical ventilator. The disclosure describes a novel approach for preventing a patient from being moved from a first location to second different location that is connected to a monitoring and/or treatment system, before all of the necessary hoses have been disconnected from the patient. Further, the disclosure describes a novel approach of ensuring that all of the necessary hoses are reconnected to a patient being monitored or treated by a monitoring and/or treatment system after being moved from the first location to the second different location.

Methods and systems for managing a patient move

Systems and methods for determining patient fatigue during ventilation of a patient are described. Novel notification and/or management of patient fatigue during ventilation are described. Further, system and methods for preventing diaphragm fatigue or weakness are described.

Systems and methods for monitoring, managing, and preventing fatigue during ventilation

This disclosure describes systems and methods for providing an optimized proportional assist breath type during ventilation of a patient. The disclosure describes a novel breath type that delivers a target airway pressure calculated based on a desired patient effort range to a triggering patient.

Methods and systems for an optimized proportional assist ventilation

This disclosure describes systems and methods for providing drive pressure ventilation of a patient. The disclosure describes a novel breath type that provides a spontaneous breath type that allows for the calculation of drive pressure that does not require invasive monitoring, where drive pressure is the pressure applied to the lungs that causes them to inflate during mechanical ventilation.

A breathing support system is provided. The system may include a breathing support device configured to deliver gas to a patient and a display device associated with the breathing support device. The display device may be configured to display a work of breathing graphic indicating one or more work of breathing measures regarding the patient's breathing.

Work of breathing display for a ventilation system

This disclosure describes systems and methods for determining patient fatigue during ventilation of a patient. The disclosure describes novel notification and/or management of patient fatigue during ventilation. Further, the disclosure describes system and methods for preventing diaphragm fatigue or weakness.

Methods and systems are presented for monitoring a clinical procedure using regional blood oxygen saturation (rSO) of a subject. The rSOof a subject is monitored, and clinical information is received, indicating that the subject is undergoing a clinical procedure (e.g., an infusion pump procedure for sodium nitroprusside administration). A change in the rSOof the subject is detected, which may be indicative of a circulatory system impairment (e.g., elevated venous oxygen saturation) caused by the clinical procedure. Status information, which may be indicative of an increased risk of a physiological event (e.g., cyanide toxicity) is determined for the subject based on the clinical information and the detected change in the rSOof the subject. Corrective actions may be triggered based on the status information in order to reduce the increased risk. The corrective actions may be implemented as smart prompt or closed loop systems.

Systems and methods for monitoring clinical procedures using regional blood oxygen saturation

Growing community of inventors

Vista, CA, United States of America

Peter Doyle